Results 1 to 10 of about 331,867 (153)

Peep into anti-vascular endothelial growth factor [PDF]

open access: yesIndian Journal of Ophthalmology
Anti-vascular endothelial growth factor (anti-VEGF) therapy has transformed the management of retinal vascular diseases over the past two decades. Beginning with the foundational identification of VEGF as the principal driver of ocular neovascularization,
Lalit Verma   +2 more
doaj   +3 more sources

Anti-vascular endothelial growth factor therapies in ophthalmology. [PDF]

open access: yesMed Hypothesis Discov Innov Ophthalmol
Background: Retinal diseases, including neovascular age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion, are leading causes of vision loss worldwide. The introduction of anti-vascular endothelial growth factor (anti-VEGF) therapies has dramatically changed the management of these conditions, offering targeted treatment ...
Koksaldi S, Karti O, Saatci AO.
europepmc   +4 more sources

Newer anti-vascular endothelial growth factor agents

open access: yesTNOA Journal of Ophthalmic Science and Research, 2020
Ocular angiogenesis is a major cause of ocular morbidity worldwide. Vascular endothelial growth factor (VEGF) is a critical regulator of angiogenesis and vascular permeability with diverse roles both during the development and adulthood. This is believed
Priya Rasipuram Chandrasekaran
doaj   +2 more sources

Pleurodesis Is Inhibited by Anti-Vascular Endothelial Growth Factor Antibody

open access: yesChest, 2005
The intrapleural injection of transforming growth factor (TGF)-beta2 produces pleurodesis in rabbits associated with large pleural effusions. This study investigated whether anti-vascular endothelial growth factor (VEGF) antibody has any effect on the fluid production or the pleurodesis induced by TGF-beta2.Three groups of seven New Zealand white ...
Ioannis Kalomenidids   +2 more
exaly   +4 more sources

Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Retinal Disorders

open access: yesPharmaceuticals, 2023
Vascular endothelial growth factors (VEGFs) are key mediator of retinal and choroidal neovascularization as well as retinal vascular leakage leading to macular edema.
Abraham Hang   +4 more
doaj   +3 more sources

Anti-vascular endothelial growth factor therapy in polypoidal choroidal vasculopathy [PDF]

open access: yesIndian Journal of Ophthalmology
The diagnosis and management of polypoidal choroidal vasculopathy (PCV), a complex chorioretinal disease which constitutes 60% of neovascular age-related macular degeneration cases among Asians, have evolved significantly in the last decade.
Anantharaman Giridhar   +2 more
doaj   +2 more sources

Anti-Vascular Endothelial Growth Factor Therapy in Breast Cancer

open access: yesInternational Journal of Molecular Sciences, 2014
Neo-angiogenesis is a critical process for tumor growth and invasion and has become a promising target in cancer therapy. This manuscript reviews three currently relevant anti-angiogenic agents targeting the vascular endothelial growth factor system: bevacizumab, ramucirumab and sorafenib. The efficacy of anti-angiogenic drugs in adjuvant therapy or as
Daniela Grimm   +2 more
exaly   +4 more sources

Anti-Vascular Endothelial Growth Factor Combined with Dexamethasone Implant Therapy for Macular Edema: A Randomized Controlled Trial [PDF]

open access: yesDrug Design, Development and Therapy
Yunxi Ma, Junwen Wang, Mingzhu Yuan, Zimeng Zeng, Yuhe Tan, Lu Cao, Xufang Sun Department of Ophthalmology, Hubei Key Laboratory of Otolaryngologic and Ophthalmic Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and ...
Ma Y   +6 more
doaj   +2 more sources

Anti-cancer effects of F16: A novel vascular endothelial growth factor receptor–specific inhibitor

open access: yesTumor Biology, 2017
Vascular endothelial growth factor receptor-2 is a dynamic target for therapeutic intervention in various types of cancers. This study was aimed to explore the anti-angiogenic activity of a novel vascular endothelial growth factor receptor–specific ...
Appu Rathinavelu   +3 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy